Vinblastine and erythromycin: an unrecognized serious drug interaction
- PMID: 7805175
- DOI: 10.1007/BF00686546
Vinblastine and erythromycin: an unrecognized serious drug interaction
Abstract
Vinblastine and erythromycin are among the most commonly used chemotherapeutic and antimicrobial agents, respectively. No interaction between the two has ever been reported. Towards the end of a phase I study of vinblastine plus oral cyclosporin (to reverse multidrug resistance), three patients also received erythromycin to raise their cyclosporin levels. All developed severe toxicity consistent with a much higher vinblastine dose than was actually given. This apparent potentiation of vinblastine toxicity has not been previously described.
Comment in
-
Vinca alkaloids and macrolides in human immunodeficiency virus-related malignancies: a safe association.Cancer Chemother Pharmacol. 1996;39(1-2):176-7. doi: 10.1007/s002800050556. Cancer Chemother Pharmacol. 1996. PMID: 8995518 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical